Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H30O3 |
| Molecular Weight | 354.4825 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)[C@@]1(O)C(=C)C[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChI
InChIKey=OKHAOBQKCCIRLO-IBVJIVQJSA-N
InChI=1S/C23H30O3/c1-13-10-17-18(21(4)8-6-16(25)12-19(13)21)7-9-22(5)20(17)11-14(2)23(22,26)15(3)24/h10,12,17-18,20,26H,2,6-9,11H2,1,3-5H3/t17-,18+,20+,21-,22+,23+/m1/s1
| Molecular Formula | C23H30O3 |
| Molecular Weight | 354.4825 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/2676933 and http://www.fda.gov/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm064715.htm
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/2676933 and http://www.fda.gov/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm064715.htm
Melengestrol is a steroidal progestin and antineoplastic agent which was never marketed. An acylated derivative, melengestrol acetate, is used as a growth promoter in animals. Melengestrol acetate (MGA) is one of six steroidal hormone growth promoters approved for use in Canada and USA. These products are used to improve growth rate and feed efficiency, as well as to suppress estrus in beef heifers (CFIA 2008). They are not approved for use in any species other than beef cattle meant for slaughter. MGA is the only drug of its kind that is administered in animal feed, and its labelled dose in Canada is 0.4mg per heifer per day (CFIA 2008). A mandatory withdrawal of 2 days before slaughter is applied to any animal that is administered MGA.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: C. albicans growth Sources: https://www.ncbi.nlm.nih.gov/pubmed/24277040 |
|||
Target ID: CHEMBL208 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15713363 |
0.418 nM [IC50] | ||
Target ID: Rat prostatic tumor growth Sources: http://www.ncbi.nlm.nih.gov/pubmed/2268413 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | HEIFERMAX 500 Approved UseFor increased rate of weight gain, improved feed efficiency, suppression of estrus in Heifers. Launch Date2004 |
|||
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/vet/heifermax-500.html
Melengestrol (HEIFERMAX® 500) should be thoroughly mixed in liquid Type C medicated feed which must be fed at 0.5 to 2.0 pounds per head daily to provide 0.25 to 0.5 mg of melengestrol acetate per head per day. Average daily intakes approximating the middle of this range provide the most optimal and economical improvements in rate of weight gain and feed utilization. Constant daily intakes of 0.35 to 0.50 mg per head per day give a high degree of estrus suppression. Levels of 0.25 to 0.35 mg provide a lower but still effective degree of estrus suppression.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22890510
Total body mass and snout-vent length of X. laevis larvae were significantly reduced by the 100 ng/L melengestrol
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:32:40 GMT 2025
by
admin
on
Mon Mar 31 19:32:40 GMT 2025
|
| Record UNII |
BX98J4T6JU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 558.342
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
||
|
NCI_THESAURUS |
C776
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
227-073-3
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
SUB08722MIG
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
C1659
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
DTXSID00204869
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
5633-18-1
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
100000081466
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
DB11529
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
MELENGESTROL
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
BX98J4T6JU
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
1537799
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | RxNorm | ||
|
BX98J4T6JU
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
1528
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
9906614
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL1328968
Created by
admin on Mon Mar 31 19:32:40 GMT 2025 , Edited by admin on Mon Mar 31 19:32:40 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
IMPURITY -> PARENT | |||
|
|
IMPURITY -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |